Skip to main content
logo
Celyad Oncology SA (EBR:CYAD)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.2700
+0.0140 (5.47%)
Aug 11, 2026, 11:24 AM CET

Celyad Oncology Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.020.020.190.1--
Revenue Growth
-88.71%-88.71%82.35%---
Gross Profit
0.010.010.170.03--
Operating Income
0.880.88-5.86-8.46-40.86-26.39
Net Income
0.830.83-5.82-8.45-40.94-26.51
Earnings Per Share
0.020.02-0.14-0.33-1.81-1.70
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.711.714.2712.4530.02
Total Debt
0.620.625.745.935.288.85
Net Cash (Debt)
1.091.09-1.541.087.1721.17
Net Cash Growth
----85.00%-66.14%135.13%
Net Cash Per Share
0.030.03-0.040.040.321.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.9-6.9-5.68-15.2-28.01-26.64
Capital Expenditures
----0.9-0.12-0.33
Free Cash Flow
-6.9-6.9-5.68-16.1-28.13-26.97
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
61.90%61.90%93.01%32.35%--
Operating Margin
4195.24%4195.24%-3149.46%-8291.18%--
Pretax Margin
3952.38%3952.38%-3131.18%-8344.12%--
Profit Margin
3952.38%3952.38%-3131.18%-8282.35%--
FCF Margin
-32857.10%-32857.10%-3053.76%-15785.30%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.229.44----
PS Ratio
545.67362.36158.59158.40--